A rare complication after aortocoronary bypass: acute cholestatic hepatitis and agranulocytosis induced by ticlopidin and simvastatin in patients allergic to salicilates

Česká verzia

Authors: J. Málková ¹; I. Hoffmanová ²; J. Knot ¹; J. Votava ³
Authors place of work: III. interní - kardiologická klinika 3. lékařské fakulty UK a FN Královské Vinohrady, Praha, přednosta prof. MUDr. Petr Widimský, DrSc., FESC ¹; II. interní klinika 3. lékařské fakulty UK a FN Královské Vinohrady, Praha, přednosta prof. MUDr. Michal Anděl, CSc. ²; Kardiochirurgická klinika 3. lékařské fakulty UK a FN Královské Vinohrady, Praha, přednosta prof. MUDr. Zbyněk Straka, CSc. ³
Published in the journal: Vnitř Lék 2005; 51(11): 1303-1305
Category: The case

Předneseno na semináři Kardiocentra 3. LF UK a FN Královské Vinohrady v Praze v roce 2004.

Summary

Unusual case of acute cholestatic hepatitis and agranulocytosis associated with the use of antiplatelet agent ticlopidine and simvastatine in patient with ASA intolerance after CABG is reported.

Keywords:
ticlopidine – simvastatin – aortocoronary – bypass – clopidogrel – agranulocytosis – cholestatic hepatitis

Zdroje

1. Golomb BA. Statin Adverse Effects: Implications for the Elderly. Geriatric Times 2004; V/3, 2-6.

2. Gotto A, Pownall H. Manual of Lipid Disorders. Reducing the Risk for Coronary Heart Disease. 3rd ed. Philadelphia: Lippincott, Williams  Wilkins 2002; 318-319.

3. Liu ZC, Uetrecht JP. Metabolism of ticlopidine by activated neutrophils: implications for ticlopidine-induced agranulocytosis. Drug Metab Dispos 2000; 28: 723-730.

4. Gandolfi A, Mengoli M, Rota E et al. Ticlopidine-induced acute cholestatic hepatitis. A case report. Recenti Prog Med 2004; 95: 96-99.

5. Waguri N, Yamamoto M. Intrahepatic cholestasis and pure red cell aplasia associated with ticlopidine. Eur J Intern Med 2003; 5: 192-195.

6. Skurnik YD, Tcherniak A, Edlan K et al. Ticlopidine-induced cholestatic hepatitis. Ann Pharmacother 2003; 37: 371-375.

7. Bhatt DL, Chew DP, Hirsch AT et al. Superiority of Clopidogrel versus Aspirin in Patients With Prior Cardiac Surgery. Circulation 2001; 103: 363-368.

8. Hirsch J, Bhatt DL. Comparative Benefits of Clopidogrel and Aspirin in High Risk Patient Populations. Arch Intern Med 2004; 164: 2106-2110.

9. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-88.

10. Špinar J, Vítovec J. ASA - je nám vše jasné? Vnitř Lék 2002; 48: 781-790.

11. Vítovec J, Špinar J et al. Farmakoterapie kardiovaskulárních onemocnění. Praha: Grada Publishing 2004: 130-131, 179.